Search

Your search keyword '"Cho, Cliff"' showing total 29 results
Start Over Author "Cho, Cliff"
29 results on '"Cho, Cliff"'

6. Indications and outcomes of enucleation versus formal pancreatectomy for pancreatic neuroendocrine tumors

Author

Heidsma, Charlotte M., Tsilimigras, Diamantis I., van Dieren, Susan, Rocha, Flavio, Abbott, Daniel E., Fields, Ryan, Smith, Paula M., Poultsides, George A., Cho, Cliff, Dillhoff, Mary, Lopez-Aguiar, Alexandra G., Kanji, Zaheer, Fisher, Alexander, Krasnick, Bradley A., Idrees, Kamran, Makris, Eleftherios, Beems, Megan, van Eijck, Casper H.J., Nieveen van Dijkum, Elisabeth J.M., Maithel, Shishir K., and Pawlik, Timothy M.

Published
2021
Full Text
View/download PDF

7. Low Prognostic Nutritional Index Is Common and Associated with Poor Outcomes following Curative-Intent Resection for Gastro-Entero-Pancreatic Neuroendocrine Tumors.

Author

Xiang, Jun-Xi, Qian, Ye-Rong, He, Jin, Lopez-Aguiar, Alexandra G., Poultsides, George, Rocha, Flavio, Weber, Sharon, Fields, Ryan, Idrees, Kamran, Cho, Cliff, Maithel, Shishir K., Lv, Yi, Zhang, Xu-Feng, and Pawlik, Timothy M.

Subjects
NEUROENDOCRINE tumors, DATABASES, GASTROPARESIS, OVERALL survival, NOMOGRAPHY (Mathematics)
Abstract

Introduction: To investigate the impact of prognostic nutritional index (PNI) on short- and long-term outcomes of patients who underwent curative-intent resection for gastro-entero-pancreatic neuroendocrine tumors (GEP-NETs). Methods: Patients with GET-NETs who underwent curative-intent resection were identified from a multi-center database. The prognostic impact of clinicopathological factors including PNI on post-operative outcomes were evaluated. A novel nomogram was developed and externally validated. Results: A total of 2,099 patients with GEP-NETs were included in the training cohort; 255 patients were in the external validation cohort. Median PNI (n = 973) was 47.4 (IQR 43.1–52.4). At the time of presentation, 1,299 (61.9%) patients presented with some type of clinical symptom. Low-PNI (≤42.2) was associated with gastrointestinal symptoms, as well as nodal metastasis and distant metastasis (all p < 0.05). Patients with a low PNI had a higher incidence of severe (≥Clavien-Dindo grade IIIa: low PNI 24.9% vs. high PNI 15.4%, p = 0.001) and multiple (≥3 types of complications: low PNI 14.5% vs. high PNI 9.2%, p = 0.024) complications, as well as a worse overall survival (OS)(5-year OS, low PNI 73.7% vs. high PNI 88.5%, p < 0.001), and RFS (5-year RFS, low PNI 68.5% vs. high PNI 79.8%, p = 0.008) versus patients with high PNI (>42.2). A nomogram based on PNI, tumor grade and metastatic disease demonstrated excellent discrimination and calibration to predict OS in both the training (C-index 0.748) and two external validation (C-index 0.827, 0.745) cohorts. Conclusions: Low PNI was common and associated with worse short- and long-term outcomes among patients with GEP-NETs. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

8. Low Prognostic Nutritional Index Is Common and Associated with Poor Outcomes following Curative-Intent Resection for Gastro-Entero-Pancreatic Neuroendocrine Tumors

Author

Xiang, Jun-Xi, primary, Qian, Ye-Rong, additional, He, Jin, additional, Lopez-Aguiar, Alexandra G., additional, Poultsides, George, additional, Rocha, Flavio, additional, Weber, Sharon, additional, Fields, Ryan, additional, Idrees, Kamran, additional, Cho, Cliff, additional, Maithel, Shishir K., additional, Lv, Yi, additional, Zhang, Xu-Feng, additional, and Pawlik, Timothy M., additional

Published
2023
Full Text
View/download PDF

9. Trends in the Number of Lymph Nodes Evaluated Among Patients with Pancreatic Neuroendocrine Tumors in the United States: A Multi-Institutional and National Database Analysis

Author

Sahara, Kota, Tsilimigras, Diamantis I., Mehta, Rittal, Moro, Amika, Paredes, Anghela Z., Lopez-Aguiar, Alexandra G., Rocha, Flavio, Kanji, Zaheer, Weber, Sharon, Fisher, Alexander, Fields, Ryan, Krasnick, Bradley A., Idrees, Kamran, Smith, Paula M., Poultsides, George A., Makris, Eleftherios, Cho, Cliff, Beems, Megan, Dillhoff, Mary, Maithel, Shishir K., Endo, Itaru, and Pawlik, Timothy M.

Published
2020
Full Text
View/download PDF

10. Margin status and long-term prognosis of primary pancreatic neuroendocrine tumor after curative resection: Results from the US Neuroendocrine Tumor Study Group

Author

Zhang, Xu-Feng, Wu, Zheng, Cloyd, Jordan, Lopez-Aguiar, Alexandra G., Poultsides, George, Makris, Eleftherios, Rocha, Flavio, Kanji, Zaheer, Weber, Sharon, Fisher, Alexander, Fields, Ryan, Krasnick, Bradley A., Idrees, Kamran, Smith, Paula M., Cho, Cliff, Beems, Megan, Schmidt, Carl R., Dillhoff, Mary, Maithel, Shishir K., and Pawlik, Timothy M.

Published
2019
Full Text
View/download PDF

12. Correction to: Trends in the Number of Lymph Nodes Evaluated Among Patients with Pancreatic Neuroendocrine Tumors in the United States: A Multi-Institutional and National Database Analysis

Author

Sahara, Kota, Tsilimigras, Diamantis I., Mehta, Rittal, Moro, Amika, Paredes, Anghela Z., Lopez-Aguiar, Alexandra G., Rocha, Flavio, Kanji, Zaheer, Weber, Sharon, Fisher, Alexander, Fields, Ryan C., Krasnick, Bradley A., Idrees, Kamran, Smith, Paula M., Poultsides, George A., Makris, Eleftherios, Cho, Cliff, Beems, Megan, Dillhoff, Mary, Maithel, Shishir K., Endo, Itaru, and Pawlik, Timothy M.

Published
2020
Full Text
View/download PDF

14. Multi-institutional analysis of pancreatic adenocarcinoma demonstrating the effect of diabetes status on survival after resection

Author

Cannon, Robert M., LeGrand, Ryan, Chagpar, Ryaz B., Ahmad, Syed A., McClaine, Rebecca, Kim, Hong Jin, Rupp, Christopher, Cho, Cliff S., Brinkman, Adam, Weber, Sharon, Winslow, Emily R., Kooby, David A., Chu, Carrie K., Staley, Charles A., Glenn, Ian, Hawkins, William G., Parikh, Alexander A., Merchant, Nipun B., McMasters, Kelly M., Martin, Robert C.G., Callender, Glenda G., and Scoggins, Charles R.

Published
2012
Full Text
View/download PDF

16. Tumor burden score predicts tumor recurrence of non-functional pancreatic neuroendocrine tumors after curative resection

Author

Dong, Ding-Hui, primary, Zhang, Xu-Feng, additional, Lopez-Aguiar, Alexandra G., additional, Poultsides, George, additional, Makris, Eleftherios, additional, Rocha, Flavio, additional, Kanji, Zaheer, additional, Weber, Sharon, additional, Fisher, Alexander, additional, Fields, Ryan, additional, Krasnick, Bradley A., additional, Idrees, Kamran, additional, Smith, Paula M., additional, Cho, Cliff, additional, Beems, Megan, additional, Schmidt, Carl R., additional, Dillhoff, Mary, additional, Maithel, Shishir K., additional, and Pawlik, Timothy M., additional

Published
2020
Full Text
View/download PDF

17. Development and Validation of a Modified Eighth AJCC Staging System for Primary Pancreatic Neuroendocrine Tumors

Author

Zhang, Xu-Feng, primary, Xue, Feng, additional, Wu, Zheng, additional, Lopez-Aguiar, Alexandra G., additional, Poultsides, George, additional, Makris, Eleftherios, additional, Rocha, Flavio, additional, Kanji, Zaheer, additional, Weber, Sharon, additional, Fisher, Alexander, additional, Fields, Ryan, additional, Krasnick, Bradley A., additional, Idrees, Kamran, additional, Smith, Paula M., additional, Cho, Cliff, additional, Beems, Megan, additional, Lyu, Yi, additional, Maithel, Shishir K., additional, and Pawlik, Timothy M., additional

Published
2020
Full Text
View/download PDF

19. Resection of pancreatic neuroendocrine tumors: defining patterns and time course of recurrence

Author

Dong, Ding-Hui, primary, Zhang, Xu-Feng, additional, Lopez-Aguiar, Alexandra G., additional, Poultsides, George, additional, Makris, Eleftherios, additional, Rocha, Flavio, additional, Kanji, Zaheer, additional, Weber, Sharon, additional, Fisher, Alexander, additional, Fields, Ryan, additional, Krasnick, Bradley A., additional, Idrees, Kamran, additional, Smith, Paula M., additional, Cho, Cliff, additional, Beems, Megan, additional, Dillhoff, Mary, additional, Maithel, Shishir K., additional, and Pawlik, Timothy M., additional

Published
2020
Full Text
View/download PDF

20. Trends in the Number of Lymph Nodes Evaluated Among Patients with Pancreatic Neuroendocrine Tumors in the United States: A Multi-Institutional and National Database Analysis

Author

Sahara, Kota, primary, Tsilimigras, Diamantis I., additional, Mehta, Rittal, additional, Moro, Amika, additional, Paredes, Anghela Z., additional, Lopez-Aguiar, Alexandra G., additional, Rocha, Flavio, additional, Kanji, Zaheer, additional, Weber, Sharon, additional, Fisher, Alexander, additional, Fields, Ryan, additional, Krasnick, Bradley A., additional, Idrees, Kamran, additional, Smith, Paula M., additional, Poultsides, George A., additional, Makris, Eleftherios, additional, Cho, Cliff, additional, Beems, Megan, additional, Dillhoff, Mary, additional, Maithel, Shishir K., additional, Endo, Itaru, additional, and Pawlik, Timothy M., additional

Published
2019
Full Text
View/download PDF

26. Nomogram predicting the risk of recurrence after curative‐intent resection of primary non‐metastatic gastrointestinal neuroendocrine tumors: An analysis of the U.S. Neuroendocrine Tumor Study Group

Author

Merath, Katiuscha, primary, Bagante, Fabio, additional, Beal, Eliza W., additional, Lopez‐Aguiar, Alexandra G., additional, Poultsides, George, additional, Makris, Eleftherios, additional, Rocha, Flavio, additional, Kanji, Zaheer, additional, Weber, Sharon, additional, Fisher, Alexander, additional, Fields, Ryan, additional, Krasnick, Bradley A., additional, Idrees, Kamran, additional, Smith, Paula M., additional, Cho, Cliff, additional, Beems, Megan, additional, Schmidt, Carl R., additional, Dillhoff, Mary, additional, Maithel, Shishir K, additional, and Pawlik, Timothy M., additional

Published
2018
Full Text
View/download PDF

27. Smart Strategies for Overseas Growth.

Author

Cho, Cliff and Parra, Julian

Subjects
BUSINESS expansion, CORPORATE growth, INVESTMENTS, POLITICAL stability, ECONOMIC equilibrium, CHIEF financial officers, ELECTRONIC funds transfers
Abstract

The article offers tips for U.S. companies on how to gain success, growth, and involvement in foreign market. It suggests expanding client base through investments, noting political and economic stability, and the need for chief financial officers (CFOs) to encourage electronic payments. Moreover, the survey by Bank of America Merrill Lynch (BofAML) and a data from the U.S. Chamber of Commerce on global business and purchasing are discussed.

Published
2015

28. Smart Strategies for Securing Top Talent.

Author

Cho, Cliff and Parra, Julian

Subjects
WORKFORCE planning, BUSINESS planning, BUSINESS expansion, TALENT development, EMPLOYEE selection, UNITED States economy, CHIEF financial officers, MILLENNIALS, EMPLOYMENT
Abstract

The article offers tips for securing an effective workforce, retaining talent, and generating growth of a business which include engaging in talent development, developing strategies for hiring, and motivating the workforce. Topics discussed include a survey on the growth of the U.S. economic ratings, the role of chief financial officers (CFOs) in solving the talent-growth equation, and the growth in careers among millennials.

Published
2015

29. New Nodal Staging for Primary Pancreatic Neuroendocrine Tumors: A Multi-institutional and National Data Analysis.

Author

Zhang XF, Xue F, Dong DH, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha F, Kanji Z, Weber S, Fisher A, Fields R, Krasnick BA, Idrees K, Smith PM, Cho C, Beems M, Lv Y, Maithel SK, and Pawlik TM

Subjects
Adult, Aged, Databases, Factual, Female, Follow-Up Studies, Humans, Lymph Nodes surgery, Lymphatic Metastasis, Male, Middle Aged, Neoplasm Staging, Neuroendocrine Tumors diagnosis, Neuroendocrine Tumors mortality, Neuroendocrine Tumors surgery, Pancreatic Neoplasms diagnosis, Pancreatic Neoplasms mortality, Pancreatic Neoplasms surgery, Prognosis, ROC Curve, SEER Program, Survival Analysis, Lymph Node Excision, Lymph Nodes pathology, Neuroendocrine Tumors pathology, Pancreatic Neoplasms pathology
Abstract

Objective: To determine the prognostic role of metastatic lymph node (LN) number and the minimal number of LNs for optimal staging of patients with pancreatic neuroendocrine tumors (pNETs)., Background: Prognosis relative to number of LN metastasis (LNM), and minimal number of LNs needed to evaluate for accurate staging, have been poorly defined for pNETs., Methods: Number of LNM and total number of LN evaluated (TNLE) were assessed relative to recurrence-free survival (RFS) and overall survival (OS) in a multi-institutional database. External validation was performed using Surveillance, Epidemiology and End Results (SEER) registry., Results: Among 854 patients who underwent resection, 233 (27.3%) had at least 1 LNM. Patients with 1, 2, or 3 LNM had a comparable worse RFS versus patients with no nodal metastasis (5-year RFS, 1 LNM 65.6%, 2 LNM 68.2%, 3 LNM 63.2% vs 0 LNM 82.6%; all P < 0.001). In contrast, patients with ≥4 LNM (proposed N2) had a worse RFS versus patients who either had 1 to 3 LNM (proposed N1) or node-negative disease (5-year RFS, ≥4 LNM 43.5% vs 1-3 LNM 66.3%, 0 LNM 82.6%; all P < 0.05) [C-statistics area under the curve (AUC) 0.650]. TNLE ≥8 had the highest discriminatory power relative to RFS (AUC 0.713) and OS (AUC 0.726) among patients who had 1 to 3 LNM, and patients who had ≥4 LNM in the multi-institutional and SEER database (n = 2764)., Conclusions: Regional lymphadenectomy of at least 8 lymph nodes was necessary to stage patients accurately. The proposed nodal staging of N0, N1, and N2 optimally staged patients., Competing Interests: The authors report no conflicts of interest, (Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.)

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results